154 related articles for article (PubMed ID: 31899313)
1. Translation of pharmacogenomic drug labels into the clinic. Current problems.
Ingelman-Sundberg M
Pharmacol Res; 2020 Mar; 153():104620. PubMed ID: 31899313
[No Abstract] [Full Text] [Related]
2. Pharmacogenomic information in FDA-approved drug labels: Application to pediatric patients.
Green DJ; Mummaneni P; Kim IW; Oh JM; Pacanowski M; Burckart GJ
Clin Pharmacol Ther; 2016 Jun; 99(6):622-32. PubMed ID: 26693845
[TBL] [Abstract][Full Text] [Related]
3. FDA mulls over paperless labeling.
Young D
Am J Health Syst Pharm; 2007 Jun; 64(11):1120, 1122. PubMed ID: 17519446
[No Abstract] [Full Text] [Related]
4. Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view.
Varnai R; Szabo I; Tarlos G; Szentpeteri LJ; Sik A; Balogh S; Sipeky C
Pharmacogenomics J; 2020 Jun; 20(3):380-387. PubMed ID: 31787752
[TBL] [Abstract][Full Text] [Related]
5. Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs.
Vivot A; Boutron I; Ravaud P; Porcher R
Genet Med; 2015 Sep; 17(9):733-8. PubMed ID: 25521333
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic information in drug labels: European Medicines Agency perspective.
Ehmann F; Caneva L; Prasad K; Paulmichl M; Maliepaard M; Llerena A; Ingelman-Sundberg M; Papaluca-Amati M
Pharmacogenomics J; 2015 Jun; 15(3):201-10. PubMed ID: 25707393
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic Biomarkers: an FDA Perspective on Utilization in Biological Product Labeling.
Schuck RN; Grillo JA
AAPS J; 2016 May; 18(3):573-7. PubMed ID: 26912182
[TBL] [Abstract][Full Text] [Related]
8. Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs.
Surh LC; Pacanowski MA; Haga SB; Hobbs S; Lesko LJ; Gottlieb S; Papaluca-Amati M; Patterson SD; Hughes AR; Kim MJ; Close SL; Mosteller M; Zineh I; Dechairo B; Cohen NA
Pharmacogenomics; 2010 Dec; 11(12):1637-47. PubMed ID: 21142906
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
[TBL] [Abstract][Full Text] [Related]
10. Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing.
Drozda K; Pacanowski MA
Pharmacotherapy; 2017 Sep; 37(9):1000-1004. PubMed ID: 28605049
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic biomarkers in drug labels: what do they tell us?
Tutton R
Pharmacogenomics; 2014 Feb; 15(3):297-304. PubMed ID: 24533709
[TBL] [Abstract][Full Text] [Related]
12. Developing Pharmacogenomic Reports: Insights from Patients and Clinicians.
Jones LK; Kulchak Rahm A; Gionfriddo MR; Williams JL; Fan AL; Pulk RA; Wright EA; Williams MS
Clin Transl Sci; 2018 May; 11(3):289-295. PubMed ID: 29316365
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic data submissions to the FDA: clinical pharmacology case studies.
Ruaño G; Collins JM; Dorner AJ; Wang SJ; Guerciolini R; Huang SM
Pharmacogenomics; 2004 Jul; 5(5):513-7. PubMed ID: 15212588
[No Abstract] [Full Text] [Related]
14. Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment.
Tan-Koi WC; Lim ES; Teo YY
Pharmacogenomics J; 2017 Mar; 17(2):121-127. PubMed ID: 26902540
[TBL] [Abstract][Full Text] [Related]
15. Implementing a personalized medicine program in a community health system.
Dressler LG; Bell GC; Ruch KD; Retamal JD; Krug PB; Paulus RA
Pharmacogenomics; 2018 Nov; 19(17):1345-1356. PubMed ID: 30345883
[TBL] [Abstract][Full Text] [Related]
16. An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
Zhou Y; Mkrtchian S; Kumondai M; Hiratsuka M; Lauschke VM
Pharmacogenomics J; 2019 Apr; 19(2):115-126. PubMed ID: 30206299
[TBL] [Abstract][Full Text] [Related]
17. The FDA announces new drug labeling for pharmacogenetic testing: is personalized medicine becoming a reality?
Vladutiu GD
Mol Genet Metab; 2008 Jan; 93(1):1-4. PubMed ID: 18054511
[No Abstract] [Full Text] [Related]
18. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
[TBL] [Abstract][Full Text] [Related]
19. Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling.
Vaduganathan M; Sathiyakumar V; Singh A; McCarthy CP; Qamar A; Januzzi JL; Scirica BM; Butler J; Cannon CP; Bhatt DL
J Am Coll Cardiol; 2018 Dec; 72(25):3370-3372. PubMed ID: 30409566
[No Abstract] [Full Text] [Related]
20. With your genes? Take one of these, three times a day.
Abbott A
Nature; 2003 Oct; 425(6960):760-2. PubMed ID: 14574377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
